If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTarsus Regulatory News (TRS)

  • There is currently no data for TRS

Corporate Update

14 Sep 2009 07:00

RNS Number : 9502Y
Tarsus Group PLC
14 September 2009
 



14 September 2009

Tarsus Group plc

Corporate Update

Tarsus Group plc ('Tarsus' or 'the Group' or 'the Company'), the international business-to-business media group, is pleased to announce the following corporate update for the period since the announcement of its record interim results on 29th July 2009..

France

The Group has disposed of its 50% shareholding in MD Management SAS to its joint venture partner, Reed Exhibitions France, for a net cash consideration of £ 0.4 million. 

This transaction has resulted in a small book profit and continues the strategy of rationalising the Group's portfolio to focus on larger events, with established brands, which tend to be more resilient throughout the economic cycle.

China

Tarsus has entered into an agreement with its joint venture partner Hubei Hope to invest together a further RMB 10 million (approximately £ 0.9 million) of cash into their joint venture, Tarsus Hope.

The monies will be used to fund acquisitions and new launches in the joint venture's core exhibition sectors of medical equipment and industrial equipment in Central China. The investment is conditional on Chinese regulatory approval, but marks a further step in the development of the Group's portfolio of events in one of the fastest growing exhibition markets in the world.

Trading

The Group's second half exhibitions have begun well, with the Off-Price Show in Las Vegas in August and the Medical event in San Jose in September both now currently trading slightly ahead of management's previous expectations.

Importantly, revenues for the two largest exhibitions in Tarsus' portfolio, Labelexpo Europe in September and the Dubai Airshow in November, continue to remain comfortably ahead of the comparable events in 2007. 

Douglas Emslie, Group Managing Director, said:

"We continue to execute against our strategy of increasing our business in the faster growing emerging markets while actively managing our portfolio in our mature markets.

 Trading for the Group for the full year continues to be in line with the Board's expectations and we anticipate a very satisfactory outcome for 2009."

For further information please contact:

Tarsus Group plc

Douglas Emslie, Group Managing Director 020 8846 2700

Ashley Milton, Group Finance Director 020 8846 2700

Media

Matthew Moth, Madano Partnership 020 7593 4000

Investor Relations

Neville Harris, IR Focus 020 7593 4015

Stephen ScottJeremy Wiseman, Scott Harris 020 7653 0030

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCLBMITMMTBBLL
Date   Source Headline
26th Oct 20157:00 amRNSTrading Statement
21st Oct 20153:40 pmRNSHolding(s) in Company
1st Oct 20153:12 pmRNSTotal Voting Rights
3rd Sep 20151:56 pmRNSCompletion of disposal of French Business
1st Sep 20153:12 pmRNSResult of General Meeting
21st Aug 20153:50 pmRNSHalf Yearly Report
5th Aug 20152:17 pmRNSDirector/PDMR Shareholding
3rd Aug 201512:59 pmRNSPosting of Circular
3rd Aug 201510:03 amRNSTotal Voting Rights
31st Jul 20153:32 pmRNSTotal Voting Rights
29th Jul 20153:16 pmRNSDirector/PDMR Shareholding
29th Jul 20157:00 amRNSInterim results for six months
17th Jul 20157:00 amRNSAdditional Listing
13th Jul 20157:00 amRNSDisposal
6th Jul 20157:00 amRNSAcquisition
1st Jul 20153:38 pmRNSTotal Voting Rights
23rd Jun 20156:13 pmRNSResult of AGM
4th Jun 20154:09 pmRNSScrip Dividend Circular
22nd May 20153:29 pmRNSDirector/PDMR Shareholding
22nd May 20157:00 amRNSTrading Statement
18th May 20152:05 pmRNSNotice of AGM
8th May 20154:45 pmRNSBlock Listing Six Monthly Return
5th May 20154:39 pmRNSDirector/PDMR Shareholding
1st May 20153:04 pmRNSTotal Voting Rights
10th Apr 20153:58 pmRNS2014 Annual Report
31st Mar 20153:48 pmRNSTotal Voting Rights
17th Mar 20151:40 pmRNSDirector/PDMR Shareholding
9th Mar 20154:49 pmRNSDirector/PDMR Shareholding
4th Mar 20159:43 amRNSHolding(s) in Company
4th Mar 20157:00 amRNSFinal Results
2nd Mar 201512:07 pmRNSTotal Voting Rights
24th Feb 201512:42 pmRNSNotice of Full Year Results - 4 March 2015
30th Jan 20153:43 pmRNSTotal Voting Rights
20th Jan 20157:00 amRNSAdditional Listing
9th Jan 20157:00 amRNSBoard Changes
9th Jan 20157:00 amRNSYear-end trading update
18th Dec 20143:21 pmRNSScrip Dividend Circular
21st Nov 20142:52 pmRNSDirector/PDMR Shareholding
11th Nov 20147:00 amRNSAcquisition
11th Nov 20147:00 amRNSInterim Management Statement
10th Nov 20145:15 pmRNSBlocklisting Interim Review
6th Nov 20145:13 pmRNSHolding(s) in Company
30th Sep 20143:35 pmRNSTotal Voting Rights
17th Sep 20143:03 pmRNSDirector/PDMR Shareholding
1st Sep 20146:08 pmRNSInterim Financial Report
1st Sep 20146:03 pmRNSTotal Voting Rights
15th Aug 20148:56 amRNSDirector/PDMR Shareholding
13th Aug 20144:33 pmRNSDirector/PDMR Shareholding
12th Aug 20145:12 pmRNSDirector/PDMR Shareholding
31st Jul 20145:18 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.